NCT05054140: An ongoing trial by Immunic AG
This trial is ongoing. It must report results 3 weeks, 1 day from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05054140 |
|---|---|
| Title | Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Sept. 30, 2021 |
| Completion date | Jan. 7, 2025 |
| Required reporting date | Jan. 7, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |